243 results
Oral anticoagulant dosing and bridging for VTE

- Dr. Joseph Shatzel @Clotmaster 

#VTE #DOAC #Bridging #Dosing #Oral
anticoagulant dosing ... DOAC #Bridging #Dosing ... #Rivaroxaban #Edoxaban
DOAC Cheat Sheet
 • Apixaban, Dabigatran, Edoxaban, Rivaroxaban
 • Renal Dosing
 • Common Drug interactions
 •
Apixaban, Dabigatran, Edoxaban ... Rivaroxaban • Renal Dosing ... anticoagulation #CheatSheet #dosing
DOAC: Cheat Sheet - Atrial Fibrillation, VTE Prophylaxis, VTE and Renal Dosing

Renal Dosing:
Apixaban (25% renal clearance):
VTE and Renal Dosing ... Renal Dosing ... if CrCl < 50) Edoxaban ... DOAC #CheatSheet #Dosing ... Rivaroxaban #Dabigatran #Edoxaban
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... Currently, edoxaban ... being stronger for edoxaban ... for appropriate dosing ... Malignancy #Cancer #Algorithm
â–º
Recommended antibiotics for pediatric pneumonia 

Dr. Rasha Buhumaid @RBuhumaid

#antibiotics #pediatrics #pneumonia #management #peds #dosing #pharmacology
pneumonia #management #peds ... #dosing #pharmacology
Toxidrome Algorithm
#Diagnosis #Peds #Pediatrics #Toxidrome #Algorithm #PEMSource
Toxidrome Algorithm ... #Diagnosis #Peds ... Pediatrics #Toxidrome #Algorithm
Xa Inhibitors - Apixaban and Rivaroxaban 
Oral Xa inhibitors are recommended by CHEST as first-line for
indications and edoxaban ... overview of the dosing ... #Rivaroxaban #Dosing
Pediatric Anaphylaxis Algorithm 

#Anaphylaxis #Algorithm #Pediatrics #Peds #Allergy
Pediatric Anaphylaxis Algorithm ... #Anaphylaxis #Algorithm ... #Pediatrics #Peds
Pediatric Status Epilepticus Algorithm 

#Status #Epilepticus #Algorithm #Pediatrics #Peds #Neurology #Seizure
Status Epilepticus Algorithm ... #Epilepticus #Algorithm ... #Pediatrics #Peds
BRONCHIOLITIS - Management Algorithm
#Management #Peds #Bronchiolitis #Algorithm #PEMSource
BRONCHIOLITIS - Management Algorithm ... #Management #Peds ... Bronchiolitis #Algorithm